{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T10:20:58Z","timestamp":1788344458198,"version":"build-2803163510"},"reference-count":43,"publisher":"MDPI AG","issue":"17","license":[{"start":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:00:00Z","timestamp":1787616000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Division of Nuclear Medicine, Department of Biomedical Imaging and Image-Guided Therapy"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostics"],"abstract":"<jats:p>Background: Interstitial fibrosis is a hallmark of chronic kidney disease (CKD) progression; however, its assessment currently relies on kidney biopsy, which is invasive and prone to sampling error. Fibroblast activation protein inhibitor (FAPI) positron emission tomography\/computed tomography (PET\/CT) targets activated fibroblasts and may enable non-invasive assessment of renal fibrosis. We investigated whether renal parenchymal [68Ga]Ga-FAPI uptake reflects histological fibrosis and evaluated its performance in highly fibrotic kidneys. Methods: In this prospective single-center study, 23 patients undergoing clinically indicated kidney biopsy underwent [68Ga]Ga-FAPI PET\/CT imaging. Standardized uptake values (SUV) of the kidneys were matched to histological fibrosis assessments as the H-score (0\u2013300), the fibrotic area (%) and intensity grade (0\u2013III). Associations were calculated by Spearman rank correlation and diagnostic performance for advanced fibrosis was evaluated by ROC analysis with leave-one-out cross-validation. Results: SUVmean correlated with H-score (\u03c1 = 0.71), fibrotic area (\u03c1 = 0.79) and intensity grade (\u03c1 = 0.74; all p &lt; 0.001), whereas SUVmax (\u03c1 = 0.17) and SUVpeak (\u03c1 = 0.29) did not. For advanced fibrosis (intensity grade III), SUVmean discriminated with an AUC of 0.89 (95% CI 0.67\u20131.00). A Youden-derived cut-off of \u22652.83 yielded cross-validated sensitivity\/specificity of 92%\/82%. Conclusions: Renal parenchymal FAPI expression, represented by SUVmean, correlates with the histological severity of interstitial fibrosis, supporting [68Ga]Ga-FAPI PET\/CT as a non-invasive tool to potentially monitor renal fibrosis over time. FAPI expression is closely linked to renal function, and subsequent larger studies are needed to validate these findings and the proposed exploratory cut-off value.<\/jats:p>","DOI":"10.3390\/diagnostics16172706","type":"journal-article","created":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T08:00:48Z","timestamp":1787644848000},"page":"2706","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Diagnostic Performance of [68Ga]Ga-FAPI PET\/CT for Differentiating Histologically Confirmed Kidney Fibrosis Severity in Advanced Chronic Kidney Disease"],"prefix":"10.3390","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3851-734X","authenticated-orcid":false,"given":"Constantin","family":"Aschauer","sequence":"first","affiliation":[{"name":"Division of Nephrology and Dialysis, Department of Medicine III, Medical University of Vienna, 1090 Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5761-0713","authenticated-orcid":false,"given":"Johannes","family":"Kl\u00e4ger","sequence":"additional","affiliation":[{"name":"Department of Pathology, Medical University of Vienna, 1090 Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1005-2985","authenticated-orcid":false,"given":"Dragan","family":"Copic","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Dialysis, Department of Medicine III, Medical University of Vienna, 1090 Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8888-440X","authenticated-orcid":false,"given":"Alexander","family":"Kainz","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Dialysis, Department of Medicine III, Medical University of Vienna, 1090 Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adelina","family":"G\u00f6llner","sequence":"additional","affiliation":[{"name":"Division of Nuclear Medicine, Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, 1090 Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4082-5731","authenticated-orcid":false,"given":"Markus","family":"Kieler","sequence":"additional","affiliation":[{"name":"Division of Nuclear Medicine, Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, 1090 Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2184-1338","authenticated-orcid":false,"given":"Lukas","family":"Kenner","sequence":"additional","affiliation":[{"name":"Department of Pathology, Medical University of Vienna, 1090 Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-0855-4676","authenticated-orcid":false,"given":"Michaela","family":"Schlederer","sequence":"additional","affiliation":[{"name":"Department of Pathology, Medical University of Vienna, 1090 Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isaia K\u00e1ssimo","family":"da Costa","sequence":"additional","affiliation":[{"name":"Department of Pathology, Medical University of Vienna, 1090 Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1591-0483","authenticated-orcid":false,"given":"Maja","family":"Nackenhorst","sequence":"additional","affiliation":[{"name":"Department of Pathology, Medical University of Vienna, 1090 Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Schmitl","sequence":"additional","affiliation":[{"name":"Division of Nuclear Medicine, Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, 1090 Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sazan","family":"Rasul","sequence":"additional","affiliation":[{"name":"Division of Nuclear Medicine, Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, 1090 Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4222-4083","authenticated-orcid":false,"given":"Marcus","family":"Hacker","sequence":"additional","affiliation":[{"name":"Division of Nuclear Medicine, Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, 1090 Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8919-2437","authenticated-orcid":false,"given":"Oana Cristina","family":"Kulterer","sequence":"additional","affiliation":[{"name":"Division of Nuclear Medicine, Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, 1090 Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,25]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/S0140-6736(19)32977-0","article-title":"The Global Burden of Chronic Kidney Disease","volume":"395","author":"Cockwell","year":"2020","journal-title":"Lancet"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Hill, N.R., Fatoba, S.T., Oke, J.L., Hirst, J.A., O\u2019Callaghan, C.A., Lasserson, D.S., and Hobbs, F.D.R. (2016). Global Prevalence of Chronic Kidney Disease\u2014A Systematic Review and Meta-Analysis. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0158765"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/s41581-025-00931-8","article-title":"Risk-Directed Management of Chronic Kidney Disease","volume":"21","author":"Blum","year":"2025","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/s41572-024-00589-9","article-title":"Chronic Kidney Disease","volume":"11","author":"Romagnani","year":"2025","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1093\/ndt\/gfaf014","article-title":"Hypertensive Nephropathy: Revisiting the Causal Link between Hypertension and Kidney Disease","volume":"40","author":"Agarwal","year":"2025","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41574-025-01171-3","article-title":"Mechanisms of Diabetic Kidney Disease and Established and Emerging Treatments","volume":"22","author":"Hilburg","year":"2026","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/s41392-023-01379-7","article-title":"Kidney Fibrosis: From Mechanisms to Therapeutic Medicines","volume":"8","author":"Huang","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/s41581-024-00925-y","article-title":"Steps Forward in the Treatment of IgA Nephropathy","volume":"21","author":"Coppo","year":"2025","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1001\/jama.2025.25020","article-title":"IgA Nephropathy in Adults: A Review","volume":"335","author":"Stoneman","year":"2026","journal-title":"JAMA"},{"key":"ref_10","unstructured":"Brett, A.S. (2021). Cardiovascular Effects of Finerenone, a New Mineralocorticoid-Receptor Antagonist. NEJM J. Watch, NA54000."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1182\/blood-2017-02-770214","article-title":"Eculizumab Cessation in Atypical Hemolytic Uremic Syndrome","volume":"130","author":"Merrill","year":"2017","journal-title":"Blood"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1182\/hematology.2020000171","article-title":"Rituximab and Eculizumab When Treating Nonmalignant Hematologic Disorders: Infection Risk, Immunization Recommendations, and Antimicrobial Prophylaxis Needs","volume":"2020","author":"Engel","year":"2020","journal-title":"Hematol. Am. Soc. Hematol. Educ. Program."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.2215\/CJN.01920218","article-title":"Complications of Immunosuppression in Glomerular Disease","volume":"13","author":"Jefferson","year":"2018","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1093\/ckj\/sfx038","article-title":"Infectious Complications of Rituximab Therapy in Renal Disease","volume":"10","author":"Nixon","year":"2017","journal-title":"Clin. Kidney J."},{"key":"ref_15","first-page":"461","article-title":"Infectious Complications of a Rituximab-Based Immunosuppressive Regimen in Patients with Glomerular Disease","volume":"10","author":"Trivin","year":"2017","journal-title":"Clin. Kidney J."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1369\/0022155419852932","article-title":"Renal Inflammation and Fibrosis: A Double-Edged Sword","volume":"67","author":"Black","year":"2019","journal-title":"J. Histochem. Cytochem."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1055\/s-0039-1688422","article-title":"Complications of Percutaneous Renal Biopsy","volume":"36","author":"Bakdash","year":"2019","journal-title":"Semin. Interv. Radiol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1053\/j.ajkd.2012.02.330","article-title":"Bleeding Complications of Native Kidney Biopsy: A Systematic Review and Meta-Analysis","volume":"60","author":"Corapi","year":"2012","journal-title":"Am. J. Kidney Dis."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1159\/000328901","article-title":"Outpatient versus Inpatient Observation after Percutaneous Native Kidney Biopsy: A Cost Minimization Study","volume":"34","author":"Maripuri","year":"2011","journal-title":"Am. J. Nephrol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.34067\/KID.0000000000000283","article-title":"Spatial Heterogeneity of Glomerular Phenotypes Affects Kidney Biopsy Findings","volume":"4","author":"Schaub","year":"2023","journal-title":"Kidney360"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1681\/ASN.2021070998","article-title":"Estimating Nephron Number from Biopsies: Impact on Clinical Studies","volume":"33","author":"Morozov","year":"2022","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.ekir.2021.11.026","article-title":"Increasing Incidence of Inadequate Kidney Biopsy Samples Over Time: A 16-Year Retrospective Analysis From a Large National Renal Biopsy Laboratory","volume":"7","author":"Nissen","year":"2022","journal-title":"Kidney Int. Rep."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.2215\/CJN.13611119","article-title":"The Importance of Kidney Medullary Tissue for the Accurate Diagnosis of BK Virus Allograft Nephropathy","volume":"15","author":"Nankivell","year":"2020","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"eaat4865","DOI":"10.1126\/scitranslmed.aat4865","article-title":"Elastin Imaging Enables Noninvasive Staging and Treatment Monitoring of Kidney Fibrosis","volume":"11","author":"Sun","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.kint.2021.04.032","article-title":"Basic Principles and New Advances in Kidney Imaging","volume":"100","author":"Caroli","year":"2021","journal-title":"Kidney Int."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1111\/ajt.15742","article-title":"Diagnostic Yield of 18F-FDG PET\/CT Imaging and Urinary CXCL9\/Creatinine Levels in Kidney Allograft Subclinical Rejection","volume":"20","author":"Hanssen","year":"2020","journal-title":"Am. J. Transplant."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.nephro.2018.11.007","article-title":"18F-FDG positron emission tomography in non-oncological renal pathology: Current indications and perspectives","volume":"15","author":"Hanssen","year":"2019","journal-title":"Nephrol. Ther."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"e222389","DOI":"10.1148\/radiol.222389","article-title":"Evaluation of Intestinal Fibrosis with 68Ga-FAPI PET\/MR Enterography in Crohn Disease","volume":"307","author":"Scharitzer","year":"2023","journal-title":"Radiology"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Lartey, D.A., Schilder, L.A., Zwezerijnen, G.J.C., D\u2019Haens, G.R.A.M., Grootjans, J., and L\u00f6wenberg, M. (2025). FAPi PET\/CT Imaging to Identify Fibrosis in Immune-Mediated Inflammatory Diseases. Biomedicines, 13.","DOI":"10.20944\/preprints202502.0803.v1"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"102598","DOI":"10.1016\/j.eclinm.2024.102598","article-title":"FAPi PET\/CT for Assessment and Visualisation of Active Myositis-Related Interstitial Lung Disease: A Prospective Observational Pilot Study","volume":"72","author":"Kastrati","year":"2024","journal-title":"EClinicalMedicine"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1093\/ckj\/sfx083","article-title":"Patterns of Progression of Chronic Kidney Disease at Later Stages","volume":"11","author":"Azevedo","year":"2018","journal-title":"Clin. Kidney J."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"3493","DOI":"10.1007\/s00259-021-05343-x","article-title":"Value of [68Ga]Ga-FAPI-04 Imaging in the Diagnosis of Renal Fibrosis","volume":"48","author":"Zhou","year":"2021","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"sfae340","DOI":"10.1093\/ckj\/sfae340","article-title":"Non-Invasive Assessment of IgA Nephropathy Severity with [18F]AlF-NOTA-FAPI-04 PET\/CT Imaging","volume":"17","author":"Wang","year":"2024","journal-title":"Clin. Kidney J."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"sfae064","DOI":"10.1093\/ckj\/sfae064","article-title":"[18F] AlF-NOTA-FAPI-04 PET\/CT for Non-Invasive Assessment of Tubular Injury in Kidney Diseases","volume":"17","author":"Wang","year":"2024","journal-title":"Clin. Kidney J."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.1007\/s00259-021-05660-1","article-title":"[68 Ga]Ga-FAPI Uptake Correlates with the State of Chronic Kidney Disease","volume":"49","author":"Conen","year":"2022","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/BF02294183","article-title":"Sample Size Requirements for Estimating Pearson, Kendall and Spearman Correlations","volume":"65","author":"Bonett","year":"2000","journal-title":"Psychometrika"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"294","DOI":"10.3758\/s13428-016-0702-8","article-title":"Confidence Intervals for Correlations When Data Are Not Normal","volume":"49","author":"Bishara","year":"2017","journal-title":"Behav. Res. Methods"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"310","DOI":"10.2214\/AJR.10.4923","article-title":"A Systematic Review of the Factors Affecting Accuracy of SUV Measurements","volume":"195","author":"Adams","year":"2010","journal-title":"Am. J. Roentgenol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/j.kint.2024.03.011","article-title":"Evidence from the Large VALIGA Cohort Validates the Subclassification of Focal Segmental Glomerulosclerosis in IgA Nephropathy","volume":"105","author":"Bellur","year":"2024","journal-title":"Kidney Int."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/nrneph.2014.92","article-title":"Pathology of IgA Nephropathy","volume":"10","author":"Roberts","year":"2014","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s40658-022-00487-7","article-title":"Comparison of Image Quality and Spatial Resolution between 18F, 68Ga, and 64Cu Phantom Measurements Using a Digital Biograph Vision PET\/CT","volume":"9","author":"Braune","year":"2022","journal-title":"EJNMMI Phys."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Cahenzli, M.A., Kreusch, A.S., Huber, P., Dressler, M., Blautzik, J.P., and Sommer, G. (2025). Furosemide Reduces Radionuclide Activity in the Bladder in 18F-PSMA-1007-PET\/CT: A Single-Center Retrospective Intra-Individual Comparative Study. Diagnostics, 15.","DOI":"10.3390\/diagnostics15151931"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"15353508241245265","DOI":"10.1177\/15353508241245265","article-title":"Combining Nuclear Medicine With Other Modalities: Future Prospect for Multimodality Imaging","volume":"23","author":"Archibald","year":"2024","journal-title":"Mol. Imaging"}],"container-title":["Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4418\/16\/17\/2706\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T10:08:50Z","timestamp":1788343730000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4418\/16\/17\/2706"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,25]]},"references-count":43,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["diagnostics16172706"],"URL":"https:\/\/doi.org\/10.3390\/diagnostics16172706","relation":{},"ISSN":["2075-4418"],"issn-type":[{"value":"2075-4418","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,25]]}}}